METTL3 and neoplasm: Some researchers suggest that the methyltransferase-like 3 (METTL3)-catalyzed m6A modification plays a critical role in the occurrence of CRC, wherein it facilitates tumor growth by suppressing YPEL5 expression in an m6A-YTHDF2-dependent manner 5.